Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans
In physiological conditions this receptor is down-regulated while with aging its expression increases, probably due to the accumulation of ligands which, through positive feedback, regulate the expression of receptor itself [40, 41, 42]
** CGM provides valuable insight when starting, changing, or adjusting GLP-1 dosing Medications can work differently from person to person, especially when they are taking different medications to help manage diabetes
Some studies have raised concerns that GLP-1 receptor agonists like Ozempic may increase the risk of pancreatic inflammation, which could contribute to the development of cancer
Note that only the liquid liposomal form is truly effective since the lyophilization process for creating capsules destroys the liposomes